Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Benson

Showing results (851-860 of 916) with videos related to

Pageof 92
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2017
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trialsF Bonnetain, C Borg, R R Adams, et al.
The Lancet. Gastroenterology & Hepatology|January 13, 2022
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton, et al.
Open Forum Infectious Diseases|March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral TherapyCynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
JAMA|December 1, 2024
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA PanelRajesh T Gandhi, Raphael J Landovitz, Paul E Sax, et al.
Annals of Internal Medicine|February 26, 2024
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2Catharine I Paules, Jing Wang, Kay M Tomashek, et al.
Epilepsia|March 16, 2024
Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosisRobert J Carton, Michael G Doyle, Hugh Kearney, et al.
The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.
Annals of Clinical and Translational Neurology|November 13, 2023
Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onsetVinicius A Schoeps, Xiaoyuan Zhou, Mary K Horton, et al.
Annals of Clinical and Translational Neurology|August 19, 2021
Gut microbiome is associated with multiple sclerosis activity in childrenMary K Horton, Kathryn McCauley, Douglas Fadrosh, et al.
European Journal of Human Genetics : EJHG|April 3, 2020
A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disabilityKatherine A Benson, Maire White, Nicholas M Allen, et al.
Pageof 92

Showing results (851-860 of 916) with videos related to

Sort By:
Pageof 92
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 22, 2017
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trialsF Bonnetain, C Borg, R R Adams, et al.
The Lancet. Gastroenterology & Hepatology|January 13, 2022
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton, et al.
Open Forum Infectious Diseases|March 7, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral TherapyCynthia L Gay, Ronald J Bosch, Ashley McKhann, et al.
JAMA|December 1, 2024
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA PanelRajesh T Gandhi, Raphael J Landovitz, Paul E Sax, et al.
Annals of Internal Medicine|February 26, 2024
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2Catharine I Paules, Jing Wang, Kay M Tomashek, et al.
Epilepsia|March 16, 2024
Somatic variants as a cause of drug-resistant epilepsy including mesial temporal lobe epilepsy with hippocampal sclerosisRobert J Carton, Michael G Doyle, Hugh Kearney, et al.
The New England Journal of Medicine|March 14, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisSusan Swindells, Ritesh Ramchandani, Amita Gupta, et al.
Annals of Clinical and Translational Neurology|November 13, 2023
Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onsetVinicius A Schoeps, Xiaoyuan Zhou, Mary K Horton, et al.
Annals of Clinical and Translational Neurology|August 19, 2021
Gut microbiome is associated with multiple sclerosis activity in childrenMary K Horton, Kathryn McCauley, Douglas Fadrosh, et al.
European Journal of Human Genetics : EJHG|April 3, 2020
A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disabilityKatherine A Benson, Maire White, Nicholas M Allen, et al.
Pageof 92